News Image

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results

Provided By GlobeNewswire

Last update: Mar 3, 2025

Discontinuation of BEACON-IPF following DSMB and outside expert panel recommendation

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today provided a corporate update and reported fourth quarter 2024 financial results.

Read more at globenewswire.com

PLIANT THERAPEUTICS INC

NASDAQ:PLRX (7/22/2025, 8:00:00 PM)

After market: 1.59 +0.02 (+1.27%)

1.57

+0.12 (+8.28%)



Find more stocks in the Stock Screener

Follow ChartMill for more